Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Whether Mass Campaigns With Fractional Dose PCV10 Would Accelerate Herd Protection Against Pneumococcal Transmission in Sub-Saharan Africa

NCT05175014 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT05175014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Whether Mass Campaigns With Fractional Dose PCV10 Would Accelerate Herd Protection Against Pneumococcal Transmission in Sub-Saharan Africa
Lead sponsor
Epicentre
Phase
Phase 4
Overall status
Completed
Start date
December 30, 2021
Completion date
October 3, 2023
Enrollment
44,618 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal carriage